Open AccessChemotherapy for transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
Author(s) -
Jie Wu,
Lei Song,
Danyi Zhao,
Bing Guo,
Jing Liu
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i31.10960
Subject(s) - medicine , hepatocellular carcinoma , doxorubicin , irinotecan , adverse effect , chemotherapy , gastroenterology , gemcitabine , retrospective cohort study , oncology , cancer , colorectal cancer
To compare the efficacy of different chemotherapeutic agents during conventional transarterial chemoembolization (cTACE) in the treatment of unresectable hepatocellular carcinoma (HCC).